Download PDF
Semin Neurol 2006; 26(1): 088-099
DOI: 10.1055/s-2006-933312
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Do Common Infections Cause Stroke?

Mitchell S.V Elkind1 , John W. Cole2
  • 1Department of Neurology, Gertrude H. Sergievsky Center, Columbia University, New York-Presbyterian Hospital, New York, New York
  • 2Department of Neurology, Maryland Stroke Center, University of Maryland School of Medicine, Baltimore, Maryland
Further Information

Publication History

Publication Date:
15 February 2006 (online)

    Permissions and Reprints

ABSTRACT

Infections have long been recognized as a potential, if uncommon, cause of cerebrovascular disease. In recent years, with the growing recognition of the importance of inflammation in atherosclerosis, there has been renewed interest in the possibility that common infections may participate in the atherosclerotic process or lead to stroke through other mechanisms. Specific organisms that have been implicated include Chlamydia pneumoniae, herpes viruses, human immunodeficiency virus, Helicobacter pylori, and organisms associated with periodontal infections. This article outlines the epidemiological, pathological, and laboratory evidence that these infections may be associated with atherosclerosis and stroke. Although definitive proof of an association between a specific infection and stroke is generally lacking, the accumulating evidence does indicate that several types of infections may be among the modifiable risk factors that contribute to the risk of stroke.

KEYWORDS

Infection - stroke - risk factors - Chlamydia pneumoniae - human immunodeficiency virus

REFERENCES

  • 1 Sacco R L. Risk factors, outcomes, and stroke subtypes for ischemic stroke.  Neurology. 1997;  49(suppl 4) S39-S44
    PubMedGoogle Scholar
  • 2 Zhu J, Nieto F J, Horne B D, Anderson J L, Muhlestein J B, Epstein S E. Prospective study of pathogen burden and risk of myocardial infarction or death.  Circulation. 2001;  103 45-51
    PubMedGoogle Scholar
  • 3 Espinola-Klein C, Rupprecht H J, Blankenberg S et al.. Impact of infectious burden on extent and long-term prognosis of atherosclerosis.  Circulation. 2002;  105 15-21
    CrossrefPubMedGoogle Scholar
  • 4 Bova I Y, Bornstein N M, Korczyn A D. Acute infection as a risk factor for ischemic stroke.  Stroke. 1996;  27 2204-2206
    CrossrefPubMedGoogle Scholar
  • 5 Grau A J, Buggle F, Becher H et al.. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia.  Neurology. 1998;  50 196-203
    PubMedGoogle Scholar
  • 6 Grau A J, Buggle F, Ziegler C et al.. Association between acute cerebrovascular ischemia and chronic or recurrent infection.  Stroke. 1997;  28 1724-1729
    CrossrefPubMedGoogle Scholar
  • 7 Grau A J, Brandt T, Buggle F et al.. Association of cervical artery dissection with recent infection.  Arch Neurol. 1999;  56 851-856
    CrossrefPubMedGoogle Scholar
  • 8 Meier C R, Derby L E, Jick S S, Vasilakis C, Jick H. Antibiotics and risk of subsequent first-time acute myocardial infarction.  JAMA. 1999;  281 427-431
    CrossrefPubMedGoogle Scholar
  • 9 Luchsinger J A, Pablos-Mendez A, Knirsch C, Rabinowitz D, Shea S. Antibiotic use and risk of ischemic stroke in the elderly.  Am J Med. 2001;  111 361-366
    CrossrefPubMedGoogle Scholar
  • 10 Grayston J T, Kuo C C, Wang S P, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.  N Engl J Med. 1986;  315 161-168
    PubMedGoogle Scholar
  • 11 Kuo C C, Jackson L A, Campbell L A, Grayston J T. Chlamydia pneumoniae (TWAR).  Clin Microbiol Rev. 1995;  8 451-461
    PubMedGoogle Scholar
  • 12 Chaim W, Sarov B, Sarov I, Piura B, Cohen A, Insler V. Serum IgG and IgA antibodies to chlamydia in ectopic pregnancies.  Contraception. 1989;  40 59-71
    CrossrefPubMedGoogle Scholar
  • 13 Kuo C C, Shor A, Campbell L A, Fukushi H, Patton D L, Grayston J T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.  J Infect Dis. 1993;  167 841-849
    PubMedGoogle Scholar
  • 14 Ramirez J A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis.  Ann Intern Med. 1996;  125 979-982
    PubMedGoogle Scholar
  • 15 Grayston J T, Kuo C C, Coulson A S et al.. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery.  Circulation. 1995;  92 3397-3400
    PubMedGoogle Scholar
  • 16 Maass M, Bartels C, Engel P M, Mamat U, Sievers H H. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease.  J Am Coll Cardiol. 1998;  31 827-832
    CrossrefPubMedGoogle Scholar
  • 17 Jackson L A, Campbell L A, Kuo C C, Rodriguez D I, Lee A, Grayston J T. Isolation of Chlamydia pneumoniae from a carotid artery specimen.  J Infect Dis. 1997;  176 292-295
    CrossrefPubMedGoogle Scholar
  • 18 Virok D, Kis Z, Karai L et al.. Chlamydia pneumoniae in atherosclerotic middle cerebral artery.  Stroke. 2001;  32 1973-1976
    CrossrefPubMedGoogle Scholar
  • 19 Vink A, Poppen M, Schoneveld A H et al.. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual.  Circulation. 2001;  103 1613-1617
    CrossrefPubMedGoogle Scholar
  • 20 Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link?.  Lancet. 1997;  350 430-436
    CrossrefPubMedGoogle Scholar
  • 21 Gaydos C A, Summersgill J T, Sahney N N, Ramirez J A, Quinn T C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.  Infect Immun. 1996;  64 1614-1620
    PubMedGoogle Scholar
  • 22 Kaukoranta-Tolvanen SSE, Teppo A M, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response.  Microb Pathog. 1996;  21 215-221
    PubMedGoogle Scholar
  • 23 Nadareishvili Z G, Koziol D E, Szekely B et al.. Increased CD8+ T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque.  Stroke. 2001;  32 1966-1972
    PubMedGoogle Scholar
  • 24 Linnanmäki E, Leinonen M, Ekman M R et al.. Chlamydiae pneumoniae specific circulating immune complexes in chronic coronary heart disease.  Circulation. 1993;  87 1130-1134
    PubMedGoogle Scholar
  • 25 Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl R L. Association of chlamydial infection with cerebrovascular disease.  Stroke. 1996;  27 2207-2210
    PubMedGoogle Scholar
  • 26 Kalayoglu M V, Byrne B I. Induction of macrophage foam cell formation by Chlamydia pneumoniae .  J Infect Dis. 1998;  177 725-729
    PubMedGoogle Scholar
  • 27 Morrison R P, Belland R J, Lyng K, Caldwell H D. Chlamydial disease pathogenesis: the 57-kD chlamydial hypersensitivity antigen is a stress response protein.  J Exp Med. 1989;  170 1271-1283
    PubMedGoogle Scholar
  • 28 Dahlén G H, Boman J, Birgander L S, Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease.  Atherosclerosis. 1995;  114 165-174
    CrossrefPubMedGoogle Scholar
  • 29 Kalayoglu M V, Libby P, Byrne G I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.  JAMA. 2002;  288 2724-2731
    CrossrefPubMedGoogle Scholar
  • 30 Madre J G, Garcia J L, Gonzalez R C et al.. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke.  Eur J Neurol. 2002;  9 303-306
    CrossrefPubMedGoogle Scholar
  • 31 Cook P J, Honeybourne D, Lip GYH, Beevers D G, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project.  Stroke. 1998;  29 404-410
    PubMedGoogle Scholar
  • 32 Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease.  Stroke. 1999;  30 299-305
    PubMedGoogle Scholar
  • 33 Glader C A, Stegmayr B, Boman J et al.. Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions.  Stroke. 1999;  30 2013-2018
    PubMedGoogle Scholar
  • 34 Tanne D, Haim M, Boyko V et al.. Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke.  Cerebrovasc Dis. 2003;  16 166-170
    CrossrefPubMedGoogle Scholar
  • 35 Heuschmann P U, Neureiter D, Gesslein M et al.. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study.  Stroke. 2001;  32 2253-2258
    CrossrefPubMedGoogle Scholar
  • 36 Elkind M S, Lin I F, Grayston T J, Sacco R L. Chlamydia pneumoniae and the risk of first ischemic stroke: the Northern Manhattan Stroke Study.  Stroke. 2000;  31 1521-1525
    PubMedGoogle Scholar
  • 37 Elkind M S, Sciacca R, Tondella MLC, Feikin D, Fields B, DiTullio M R. Antibodies to Chlamydia pneumoniae are associated with risk of ischemic stroke.  Neurology. 2003;  60(suppl 1) A256-A257
    PubMedGoogle Scholar
  • 38 Von Hertzen L, Alakarppa H, Koskinen R et al.. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease.  Epidemiol Infect. 1997;  118 155-164
    CrossrefPubMedGoogle Scholar
  • 39 Chaim W, Sarov B, Sarov I, Piura B, Cohen A, Insler V. Serum IgG and IgA antibodies to chlamydia in ectopic pregnancies.  Contraception. 1989;  40 59-71
    CrossrefPubMedGoogle Scholar
  • 40 Minick C R, Fabricant C G, Fabricant J, Litrenta M M. Atheroarteriosclerosis induced by infection with a herpesvirus.  Am J Pathol. 1979;  96 673-706
    PubMedGoogle Scholar
  • 41 Fabricant C G, Fabricant J, Minick C R, Litrenta M M. Herpesvirus-induced atherosclerosis in chickens.  Fed Proc. 1983;  42 2476-2479
    PubMedGoogle Scholar
  • 42 Benditt E P, Barrett T, McDougall J K. Viruses in the etiology of atherosclerosis.  Proc Natl Acad Sci USA. 1983;  80 6386-6389
    PubMedGoogle Scholar
  • 43 Ventura H O, Mehra M R, Smart F W, Stapleton D D. Cardiac allograft vasculopathy: current concepts.  Am Heart J. 1995;  129 791-798
    CrossrefPubMedGoogle Scholar
  • 44 Melnick J L, Adam E, Debakey M E. Possible role of cytomegalovirus in atherogenesis.  JAMA. 1990;  263 2204-2207
    CrossrefPubMedGoogle Scholar
  • 45 Espinola-Klein C, Rupprecht H-J, Blankenberg S et al.. Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection?.  Stroke. 2000;  31 2127-2133
    PubMedGoogle Scholar
  • 46 Sorlie P D, Nieto F J, Adam E, Folsom A R, Shahar E, Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study.  Arch Intern Med. 2000;  160 2027-2032
    CrossrefPubMedGoogle Scholar
  • 47 Muhlestein J B, Horne B D, Carlquist J F et al.. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.  Circulation. 2000;  102 1917-1923
    PubMedGoogle Scholar
  • 48 Speir E, Modali R, Huang E S et al.. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.  Science. 1994;  265 391-394
    PubMedGoogle Scholar
  • 49 Hendrix M G, Salimans M M, van Boven C P, Bruggeman C A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis.  Am J Pathol. 1990;  136 23-28
    PubMedGoogle Scholar
  • 50 Ridker P M, Hennekens C H, Stampfer M J et al.. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke.  Circulation. 1998;  98 2796-2799
    PubMedGoogle Scholar
  • 51 Lemstrom K B, Aho P T, Bruggeman C A, Hayry P J. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts: possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.  Arterioscler Thromb. 1994;  14 2043-2052
    PubMedGoogle Scholar
  • 52 Geist L J, Monick M M, Stinski M F, Hunninghake G W. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin 2 and interleukin 2 receptor genes.  Am J Respir Cell Mol Biol. 1991;  5 292-296
    PubMedGoogle Scholar
  • 53 Geist L J, Monick M M, Stinski M F, Hunninghake G W. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression.  J Clin Invest. 1994;  93 474-478
    PubMedGoogle Scholar
  • 54 Kowalik T F, Wing B, Haskill J S, Azizkhan J C, Baldwin A S, Huang E S. Multiple mechanisms are implicated in the regulation of NF-B activity during human cytomegalovirus infection.  Proc Natl Acad Sci USA. 1993;  90 1107-1111
    PubMedGoogle Scholar
  • 55 Yonemitsu Y, Kaneda Y, Komori K, Hirai K, Sugimachi K, Sueishi K. The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo.  Biochem Biophys Res Commun. 1997;  231 447-451
    CrossrefPubMedGoogle Scholar
  • 56 Pinto A N. AIDS and cerebrovascular disease.  Stroke. 1996;  27 538-545
    CrossrefPubMedGoogle Scholar
  • 57 Cole J W, Pinto A N, Hebel J R et al.. Acquired immunodeficiency syndrome and the risk of stroke.  Stroke. 2004;  35 51-56
    PubMedGoogle Scholar
  • 58 Evers S, Nabavi D, Rahmann A, Heese C, Reichelt D, Husstedt I W. Ischemic cerebrovascular events in HIV infection.  Cerebrovasc Dis. 2003;  15 199-205
    CrossrefPubMedGoogle Scholar
  • 59 Shen Y M, Frenkel E P. Thrombosis and a hypercoagulable state in HIV-infected patients.  Clin Appl Thromb Hemost. 2004;  10 277-280
    CrossrefPubMedGoogle Scholar
  • 60 Johnson R M, Barbarini G, Barbaro G. Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients.  AIDS. 2003;  17(suppl 1) S77-S82
    PubMedGoogle Scholar
  • 61 Connor M D, Lammie G A, Bell J E et al.. Cerebral infarction in adult AIDS patients: observation from the Edinburgh HIV Autopsy Cohort.  Stroke. 2000;  31 2117-2126
    CrossrefPubMedGoogle Scholar
  • 62 Trotti R, Rondanelli M, Anesi A, Gabanti E, Brustia R, Minoli L. Increased erythrocyte glutathione peroxidase activity and serum tumor necrosis factor-α in HIV-infected patients: relationship to on-going prothrombotic state.  J Hematother Stem Cell Res. 2002;  11 369-375
    CrossrefPubMedGoogle Scholar
  • 63 Schecter A D, Berman A B, Yi L et al.. HIV envelope gp120 activates human arterial smooth muscle cells.  Proc Natl Acad Sci USA. 2001;  98 10142-10147
    CrossrefPubMedGoogle Scholar
  • 64 Saif M W, Greenberg B. HIV and thrombosis: a review.  AIDS Patient Care STDS. 2001;  15 15-24
    CrossrefPubMedGoogle Scholar
  • 65 Hoffmann M, Berger J R, Nath A, Rayens M. Cerebrovascular disease in young, HIV-infected black Africans in the KwaZulu Natal Province of South Africa.  J Neurovirol. 2000;  6 229-236
    CrossrefPubMedGoogle Scholar
  • 66 Chetty R. Vasculitides associated with HIV infection.  J Clin Pathol. 2001;  54 275-278
    CrossrefPubMedGoogle Scholar
  • 67 Noel B. Vascular complications of cocaine use.  Stroke. 2002;  33 1747-1748
    CrossrefPubMedGoogle Scholar
  • 68 Wu D T, Woodman S E, Weiss J M et al.. Mechanisms of leukocyte trafficking into the CNS.  J Neurovirol. 2000;  6 S82-S85
    PubMedGoogle Scholar
  • 69 Brilla R, Nabavi D G, Schulte-Atedorneburg G et al.. Cerebral vasculopathy in HIV infection revealed by transcranial doppler: a pilot study.  Stroke. 1999;  30 811-813
    CrossrefPubMedGoogle Scholar
  • 70 Lee G A, Seneviratne T, Noor M A et al.. The metabolic effects of lopinavir/ritonavir in HIV-negative men.  AIDS. 2004;  18 641-649
    CrossrefPubMedGoogle Scholar
  • 71 Copur A S, Smith P R, Gomez V, Bergman M, Homel P. HIV infection is a risk factor for venous thromboembolism.  AIDS Patient Care STDS. 2002;  16 205-209
    CrossrefPubMedGoogle Scholar
  • 72 Wanke C A, Falutz J M, Shevitz A, Phair J P, Kotler D P. Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus.  Clin Infect Dis. 2002;  34 248-259
    CrossrefPubMedGoogle Scholar
  • 73 Dressman J, Kincer J, Matveev S V et al.. HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesterol ester accumulation in macrophages.  J Clin Invest. 2003;  111 389-397
    CrossrefPubMedGoogle Scholar
  • 74 Hui D Y. HIV protease inhibitors and atherosclerosis.  J Clin Invest. 2003;  111 317-318
    CrossrefPubMedGoogle Scholar
  • 75 Ninomiya J K, L’Italien G, Criqui M H et al.. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.  Circulation. 2004;  109 42-46
    CrossrefPubMedGoogle Scholar
  • 76 Williams R C. Periodontal disease.  N Engl J Med. 1990;  322 373-382
    PubMedGoogle Scholar
  • 77 Brown L J, Brunelle J A, Kingman A. Periodontal status in the United States, 1988-1991: prevalence, extent, and demographic variation.  J Dent Res. 1996;  75 672-683
    PubMedGoogle Scholar
  • 78 Silver J G, Martin A W, McBride B C. Experimental transient bacteremias in human subjects with varying degrees of plaque accumulation and gingival inflammation.  J Clin Periodontol. 1977;  4 92-99
    PubMedGoogle Scholar
  • 79 Engebretson S P, Lamster I B, Elkind MSV et al.. Radiographic measures of periodontal disease and carotid atherosclerosis.  Stroke. 2005;  36 561-566
    CrossrefPubMedGoogle Scholar
  • 80 Beck J, Garcia R, Heiss G, Vokonas P S, Offenbacher S. Periodontal disease and cardiovascular disease.  J Periodontol. 1996;  67 1123-1137
    PubMedGoogle Scholar
  • 81 Wu T, Trevisan M, Genco R J, Dorn J P, Falkner K L, Sempos C T. Periodontal disease and risk of cerebrovascular disease: the first National Health and Nutrition Examination Survey and its follow-up study.  Arch Intern Med. 2000;  160 2749-2755
    CrossrefPubMedGoogle Scholar
  • 82 Hujoel P P, Drangsholt M, Spiekerman C, DeRouen T A. Periodontal disease and coronary heart disease risk.  JAMA. 2000;  284 1406-1410
    CrossrefPubMedGoogle Scholar
  • 83 Veldhuyzen van Zanten S J, Sherman P M. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.  CMAJ. 1994;  150 177-185
    PubMedGoogle Scholar
  • 84 Koenig W, Rothenbacher D, Hoffmeister A et al.. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease.  Circulation. 1999;  100 2326-2331
    PubMedGoogle Scholar
  • 85 Pasceri V, Cammarota G, Patti G et al.. Association of virulent Helicobacter pylori strains with ischemic heart disease.  Circulation. 1998;  97 1675-1679
    PubMedGoogle Scholar
  • 86 Ameriso S F, Fridman E A, Leiguarda R C, Sevlever G E. Detection of Helicobacter pylori in human carotid atherosclerotic plaques.  Stroke. 2001;  32 385-391
    CrossrefPubMedGoogle Scholar
  • 87 Blasi F, Denti F, Erba M et al.. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.  J Clin Microbiol. 1996;  34 2766-2769
    PubMedGoogle Scholar
  • 88 Moazed T C, Kuo C, Grayston J T, Campbell L A. Murine models of Chlamydia pneumoniae infection and atherosclerosis.  J Infect Dis. 1997;  175 883-890
    PubMedGoogle Scholar
  • 89 Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.  Infect Immun. 1997;  65 4832-4835
    PubMedGoogle Scholar
  • 90 Muhlestein J B, Anderson J L, Hammond E H et al.. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.  Circulation. 1998;  97 633-636
    PubMedGoogle Scholar
  • 91 Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: the final report of the ROXIS Study.  Eur Heart J. 1999;  20 121-127
    CrossrefPubMedGoogle Scholar
  • 92 Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B. Reduced progression of early carotid atherosclerosis after antibiotic treatment and C. pneumoniae seropositivity.  Circulation. 2002;  106 2428-2433
    CrossrefPubMedGoogle Scholar
  • 93 Sander D, Winbeck K, Klingelhöfer J et al.. Reduced progression of early carotid atherosclerosis after antibiotic treatment and C. pneumoniae seropositivity.  Circulation. 2002;  106 2428-2433
    CrossrefPubMedGoogle Scholar
  • 94 Sander D, Winbeck K, Klingelhöfer J et al.. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.  Circulation. 2004;  109 1010-1015
    CrossrefPubMedGoogle Scholar
  • 95 O'Connor C M, Dunne M W, Pfeffer M A et al.. Azithromycin for the secondary prevention of coronary heart disease events-the WIZARD study: a randomized controlled trial.  JAMA. 2003;  290 1459-1466
    CrossrefPubMedGoogle Scholar
  • 96 Grayston J T, Kronmal R A, Jackson L A et al.. Azithromycin for the secondary prevention of coronary events.  N Engl J Med. 2005;  352 1637-1645
    CrossrefPubMedGoogle Scholar
  • 97 Cannon C P, Braunwald E, McCabe C H et al.. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.  N Engl J Med. 2005;  352 1646-1654
    CrossrefPubMedGoogle Scholar
  • 98 Prospective Studies Collaboration . Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts.  Lancet. 1995;  346 1647-1653
    CrossrefPubMedGoogle Scholar
  • 99 Espinola-Klein C, Rupprecht H J, Blankenberg S et al.. Impact of infectious burden on extent and long-term prognosis of atherosclerosis.  Circulation. 2002;  105 15-21
    CrossrefPubMedGoogle Scholar
  • 100 Espinola-Klein C, Rupprecht H J, Blankenberg S et al.. Impact of infectious burden on progression of carotid atherosclerosis.  Stroke. 2002;  33 2581-2586
    CrossrefPubMedGoogle Scholar
  • 101 Smieja M, Gnarpe J, Lonn E et al.. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.  Circulation. 2003;  107 251-257
    CrossrefPubMedGoogle Scholar
  • 102 Ezekowitz R A. Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity?.  Am J Hum Genet. 1998;  62 6-9
    CrossrefPubMedGoogle Scholar
  • 103 Hegele R A, Ban M R, Anderson C M, Spence J D. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area.  J Investig Med. 2000;  48 198-202
    PubMedGoogle Scholar
  • 104 Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection.  J Am Coll Cardiol. 2001;  38 712-717
    CrossrefPubMedGoogle Scholar

Mitchell S.V ElkindM.D. M.S. F.A.A.N. 

Assistant Professor of Neurology, Department of Neurology, Gertrude H. Sergievsky Center, Columbia University, New York-Presbyterian Hospital, 710 West 168th Street, Box 182, New York, NY 10032

      >